Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease
- 15 November 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 8 (17) , 3069-3084
- https://doi.org/10.1517/14656566.8.17.3069
Abstract
Formoterol, a long-acting beta2-adrenergic agonist, is used as an inhaled bronchodilator therapy for patients with asthma or for the prevention of exercise-induced bronchospasm in children and in chronic obstructive pulmonary disease. Formoterol has unique characteristics of rapid onset and sustained duration of action compared with other bronchodilators. In addition to its effectiveness as regular maintenance therapy in asthma and chronic obstructive pulmonary disease, formoterol is also reported to be effective as an as-needed reliever therapy in patients with asthma. Formoterol is available in several different types of dry-powder inhalers and pressurized metered-dose inhalers.Keywords
This publication has 47 references indexed in Scilit:
- In VitroComparison of Two Delivery Devices for Administering Formoterol: Foradil®P and Formoterol Ratiopharm Single-Dose Capsule InhalerJournal of Aerosol Medicine, 2006
- Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in childrenAnnals of Allergy, Asthma & Immunology, 2006
- Acute Relief of Exercise-Induced Bronchoconstriction by Inhaled Formoterol in Children With Persistent AsthmaChest, 2006
- Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group studyClinical Therapeutics, 2004
- Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutalineBritish Journal of Clinical Pharmacology, 2004
- Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adultsCurrent Medical Research and Opinion, 2004
- Formoterol 12 μg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: A multicenter, randomized, open-label, parallel-group studyClinical Therapeutics, 2003
- Formoterol provides long-lasting protection against exercise-induced bronchospasmAnnals of Allergy, Asthma & Immunology, 2002
- A Health-Related Quality-of-Life Comparison of Formoterol (Oxis®) Turbuhaler® plus Budesonide (Pulmicort®) Turbuhaler® with Budesonide Turbuhaler® Alone and Noncorticosteroid Treatment in Asthma: A Randomized Clinical Study in RussiaRespiration, 2002
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993